Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Sale | 2024-04-17 4:33 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 22,768 | $65.91 | $1,500,589 | 883,504 (Indirect Direct) | View |
| 2024-04-12 Sale | 2024-04-15 6:28 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $67.79 | $16,948 | 59,731 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:59 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $67.25 | $1,345,000 | 302,905 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-13 4:48 pm | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 250 | $66.54 | $16,635 | 59,981 (Direct) | View |
| 2024-03-11 Sale | 2024-03-13 4:44 pm | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 20,000 | $65.81 | $1,316,200 | 322,905 (Indirect Direct) | View |
| 2024-03-08 Sale | 2024-03-11 6:43 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 10,000 | $67.17 | $671,700 | 906,272 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-11 6:39 pm | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 7,787 | $65.55 | $510,438 | 177,712 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 7:25 pm | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 45,257 | $66.1 | $2,991,469 | 411,629 (Direct) | View |
| 2024-03-07 Sale | 2024-03-07 9:42 pm | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 24,338 | $66.37 | $1,615,313 | 122,458 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 9:11 pm | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 40,000 | $65.77 | $2,630,864 | 916,272 (Indirect Direct) | View |
| 2024-03-05 Sale | 2024-03-06 4:24 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 5,000 | $66 | $330,000 | 87,387 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:20 pm | ANI PHARMACEUTICALS INC | ANIP | Pera Antonio R Director | 7,000 | $65.2 | $456,400 | 26,627 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-10 Tax Withholding | 2024-04-11 9:13 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 2,799 | $66.96 | 116,006 (Direct) | View |
| 2024-04-10 Tax Withholding | 2024-04-11 9:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 4,534 | $66.96 | 166,968 (Direct) | View |
Ownership | 2024-04-08 9:53 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 0 | $0 | 34,036 (Direct) | View |
| 2024-03-23 Tax Withholding | 2024-03-25 4:17 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 6,210 | $69.58 | 171,502 (Direct) | View |
| 2024-03-23 Tax Withholding | 2024-03-25 4:14 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 3,653 | $69.58 | 118,805 (Direct) | View |
| 2024-03-23 Tax Withholding | 2024-03-25 4:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 17,455 | $69.58 | 394,174 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 6:39 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 4,216 | $66.71 | 177,712 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-08 7:25 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 17,060 | $66.71 | 411,629 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-07 9:42 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 2,034 | $66.71 | 122,458 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-07 9:21 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 2,494 | $66.71 | 80,212 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-07 9:16 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,110 | $66.71 | 85,277 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:18 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 1,122 | $67.67 | 956,272 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,275 | $67.67 | 92,387 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 1,058 | $67.67 | 148,830 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:06 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 10,014 | $67.67 | 473,946 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:03 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 1,570 | $67.67 | 82,706 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 5:01 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 1,635 | $67.67 | 342,905 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 4:59 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 1,173 | $67.67 | 51,545 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 4:57 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 1,173 | $67.67 | 60,231 (Direct) | View |
| 2024-02-29 Tax Withholding | 2024-03-01 4:55 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 1,914 | $67.67 | 189,715 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-20 5:09 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 1,244 | $57.55 | 84,276 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-20 5:02 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,261 | $57.55 | 93,662 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:56 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO | 134,216 | $0 | 483,960 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:53 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 22,367 | $0 | 957,394 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:50 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 31,316 | $0 | 94,923 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:47 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV | 16,776 | $0 | 149,888 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:38 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS | 24,605 | $0 | 85,520 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:34 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY | 22,367 | $0 | 344,540 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER | 20,131 | $0 | 52,718 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:28 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 24,605 | $0 | 61,404 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:26 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO | 35,790 | $0 | 191,629 (Direct) | View |